Assessing the Therapeutic Efficacy of Oxime Therapies Against Percutaneous Organophosphorus Pesticide and Nerve Agent Challenges in the Hartley Guinea Pig

Overview

Journal J Toxicol Sci

Specialty Toxicology

Date 2015 Nov 13

PMID 26558457

Citations 4

Authors

Thomas H Snider

Christina M Wilhelm

Michael C Babin

Gennady E Platoff Jr

David T Yeung

Affiliations

Soon will be listed here.

Abstract

Given the rapid onset of symptoms from intoxication by organophosphate (OP) compounds, a quick-acting, efficacious therapeutic regimen is needed. A primary component of anti-OP therapy is an oxime reactivator to rescue OP-inhibited acetylcholinesterases. Male guinea pigs, clipped of hair, received neat applications of either VR, VX, parathion, or phorate oxon (PHO) at the 85(th) percentile lethal dose, and, beginning with presentation of toxicosis, received the human equivalent dose therapy by intramuscular injection with two additional follow-on treatments at 3-hr intervals. Each therapy consisted of atropine free base at 0.4 mg/kg followed by one of eight candidate oximes. Lethality rates were obtained at 24 hr after VR, VX and PHO challenges, and at 48 hr after challenge with parathion. Lethality rates among symptomatic, oxime-treated groups were compared with that of positive control (OP-challenged and atropine-only treated) guinea pigs composited across the test days. Significant (p ≤ 0.05) protective therapy was afforded by 1,1-methylene bis(4(hydroxyimino- methyl)pyridinium) dimethanesulfonate (MMB4 DMS) against challenges of VR (p ≤ 0.001) and VX (p ≤ 0.05). Lethal effects of VX were also significantly (p ≤ 0.05) mitigated by treatments with oxo-[[1-[[4-(oxoazaniumylmethylidene)pyridin-1-yl]methoxymethyl]pyridin-4-ylidene]methyl]azanium dichloride (obidoxime Cl2) and 1-(((4-(aminocarbonyl) pyridinio)methoxy)methyl)-2,4-bis((hydroxyimino)methyl)pyridinium dimethanesulfonate (HLö-7 DMS). Against parathion, significant protective therapy was afforded by obidoxime dichloride (p ≤ 0.001) and 1,1'-propane-1,3-diylbis{4-[(E)-(hydroxyimino)methyl]pyridinium} dibromide (TMB-4, p ≤ 0.01). None of the oximes evaluated was therapeutically effective against PHO. Across the spectrum of OP chemicals tested, the oximes that offered the highest level of therapy were MMB4 DMS and obidoxime dichloride.

Citing Articles

Succinate prodrugs in combination with atropine and pralidoxime protect cerebral mitochondrial function in a rodent model of acute organophosphate poisoning.

Piel S, Janowska J, Ward J, McManus M, Jose J, Starr J Sci Rep. 2022; 12(1):20329.

PMID: 36434021 PMC: 9700731. DOI: 10.1038/s41598-022-24472-3.

Nanomaterial-Enabled Sensors and Therapeutic Platforms for Reactive Organophosphates.

Choi S Nanomaterials (Basel). 2021; 11(1).

PMID: 33467113 PMC: 7830340. DOI: 10.3390/nano11010224.

Kinetic analysis of oxime-assisted reactivation of human, Guinea pig, and rat acetylcholinesterase inhibited by the organophosphorus pesticide metabolite phorate oxon (PHO).

Moyer R, McGarry Jr K, Babin M, Platoff Jr G, Jett D, Yeung D Pestic Biochem Physiol. 2018; 145:93-99.

PMID: 29482737 PMC: 5830159. DOI: 10.1016/j.pestbp.2018.01.009.

Acute toxicity of phorate oxon by oral gavage in the Sprague-Dawley rat.

Snider T, McGarry K, Babin M, Jett D, Platoff Jr G, Yeung D Fundam Toxicol Sci. 2017; 3(5):195-204.

PMID: 28856079 PMC: 5573267. DOI: 10.2131/fts.3.195.

References

Bahar F, Ohura K, Ogihara T, Imai T . Species difference of esterase expression and hydrolase activity in plasma. J Pharm Sci. 2012; 101(10):3979-88. DOI: 10.1002/jps.23258. View

Clement J . Toxicology and pharmacology of bispyridium oximes--insight into the mechanism of action vs Soman poisoning in vivo. Fundam Appl Toxicol. 1981; 1(2):193-202. DOI: 10.1016/s0272-0590(81)80058-9. View

Dawson R . Review of oximes available for treatment of nerve agent poisoning. J Appl Toxicol. 1994; 14(5):317-31. DOI: 10.1002/jat.2550140502. View

Lundy P, Hansen A, Hand B, Boulet C . Comparison of several oximes against poisoning by soman, tabun and GF. Toxicology. 1992; 72(1):99-105. DOI: 10.1016/0300-483x(92)90089-w. View

Guy R, Hadgraft J, Maibach H . Percutaneous absorption in man: a kinetic approach. Toxicol Appl Pharmacol. 1985; 78(1):123-9. DOI: 10.1016/0041-008x(85)90311-4. View

Cadieux C, Broomfield C, Kirkpatrick M, Kazanski M, Lenz D, Cerasoli D . Comparison of human and guinea pig acetylcholinesterase sequences and rates of oxime-assisted reactivation. Chem Biol Interact. 2010; 187(1-3):229-33. DOI: 10.1016/j.cbi.2010.04.020. View

Czerwinski S, Skvorak J, Maxwell D, Lenz D, Baskin S . Effect of octanol:water partition coefficients of organophosphorus compounds on biodistribution and percutaneous toxicity. J Biochem Mol Toxicol. 2006; 20(5):241-6. DOI: 10.1002/jbt.20140. View

McGarry K, Bartlett R, Machesky N, Snider T, Moyer R, Yeung D . Evaluation of HemogloBind™ treatment for preparation of samples for cholinesterase analysis. Adv Biosci Biotechnol. 2014; 4(12):1020-1023. PMC: 3989896. DOI: 10.4236/abb.2013.412136. View

Shutt L, BOWES J . Atropine and hyoscine. Anaesthesia. 1979; 34(5):476-90. DOI: 10.1111/j.1365-2044.1979.tb06327.x. View

10.

Sun M, Chang Z, Shau M, Huang R, Chou T . The mechanism of ageing of phosphonylated acetylcholinesterase. Eur J Biochem. 1979; 100(2):527-30. DOI: 10.1111/j.1432-1033.1979.tb04198.x. View

11.

Bentur Y, Layish I, Krivoy A, Berkovitch M, Rotman E, Haim S . Civilian adult self injections of atropine-trimedoxime (TMB4) auto-injectors. Clin Toxicol (Phila). 2006; 44(3):301-6. DOI: 10.1080/15563650600584519. View

12.

Wilhelm C, Snider T, Babin M, Jett D, Platoff Jr G, Yeung D . A comprehensive evaluation of the efficacy of leading oxime therapies in guinea pigs exposed to organophosphorus chemical warfare agents or pesticides. Toxicol Appl Pharmacol. 2014; 281(3):254-65. PMC: 4255143. DOI: 10.1016/j.taap.2014.10.009. View

13.

Radic Z, Sit R, Garcia E, Zhang L, Berend S, Kovarik Z . Mechanism of interaction of novel uncharged, centrally active reactivators with OP-hAChE conjugates. Chem Biol Interact. 2012; 203(1):67-71. PMC: 3561488. DOI: 10.1016/j.cbi.2012.08.014. View

14.

Li H, Schopfer L, Nachon F, Froment M, Masson P, Lockridge O . Aging pathways for organophosphate-inhibited human butyrylcholinesterase, including novel pathways for isomalathion, resolved by mass spectrometry. Toxicol Sci. 2007; 100(1):136-45. DOI: 10.1093/toxsci/kfm215. View

15.

Zhang Y, Kua J, McCammon J . Role of the catalytic triad and oxyanion hole in acetylcholinesterase catalysis: an ab initio QM/MM study. J Am Chem Soc. 2002; 124(35):10572-7. DOI: 10.1021/ja020243m. View

16.

Chen V, Gao Y, Geng L, Parks R, Pang Y, Brimijoin S . Plasma butyrylcholinesterase regulates ghrelin to control aggression. Proc Natl Acad Sci U S A. 2015; 112(7):2251-6. PMC: 4343161. DOI: 10.1073/pnas.1421536112. View

17.

Lockridge O . Review of human butyrylcholinesterase structure, function, genetic variants, history of use in the clinic, and potential therapeutic uses. Pharmacol Ther. 2014; 148:34-46. DOI: 10.1016/j.pharmthera.2014.11.011. View

18.

Worek F, Eyer P, Aurbek N, Szinicz L, Thiermann H . Recent advances in evaluation of oxime efficacy in nerve agent poisoning by in vitro analysis. Toxicol Appl Pharmacol. 2006; 219(2-3):226-34. DOI: 10.1016/j.taap.2006.10.001. View

19.

Schmued L, Albertson C, Slikker Jr W . Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration. Brain Res. 1997; 751(1):37-46. DOI: 10.1016/s0006-8993(96)01387-x. View

20.

Shih T, Skovira J, ODonnell J, McDonough J . Evaluation of nine oximes on in vivo reactivation of blood, brain, and tissue cholinesterase activity inhibited by organophosphorus nerve agents at lethal dose. Toxicol Mech Methods. 2009; 19(6-7):386-400. DOI: 10.1080/15376510903213892. View